[U.S. Stock Trends] 5 Attractive Growth Stocks for the Next 10 Years | Motley Fool U.S. Stock Information | Moneyクリ MoneyX Securities' Investment Information and Money-Helpful Media

Motley Fool U.S. Headquarters, June 9, 2025, from a posted article

Now that the stock market is calming after a period of instability, it is a great opportunity to focus on attractive growth stocks that hold potential over the next decade. Here are five growth stocks from various sectors that investors may consider for long-term holding.

1. Taiwan Semiconductor Manufacturing (TSMC)

Taiwan Semiconductor Manufacturing Company (TSMC) [TSM] is one of the most important players in the artificial intelligence (AI) boom. As the world’s largest contract chip manufacturer, TSMC produces advanced semiconductors that support a wide range of products, from AI infrastructure to smartphones and automotive technology.

The manufacturing of these chips is not easy due to the need for cutting-edge technology, precise manufacturing, and scale. There are very few companies in the world with capabilities and track records like TSMC, and while competitors struggle, TSMC has also gained significant pricing power.

As a result, the company’s leadership in advanced nodes and packaging (protection, electrical connections, heat dissipation, and implementation) has made it a reliable partner for top-tier chip designers. Advanced nodes refer to manufacturing processes that allow for the integration of more transistors onto a chip, thereby improving performance and power efficiency.

On the other hand, the demand for high-performance computing, including AI chips, is exploding. As AI workloads increase, TSMC is expanding its production capacity in collaboration with major customers to meet future demand.

Despite playing a crucial role in the AI supply chain, TSMC’s stock price remains at a reasonable level. For long-term investors looking to benefit from the continued growth of AI infrastructure and semiconductors in general, TSMC is an ideal stock to hold.

2. Pinterest

Pinterest [PINS] has undergone a quiet yet powerful transformation under CEO Bill Ready. Over the past three years, the company has made significant investments in technology, turning its massive user base of over 570 million monthly active users worldwide into a growth engine. Pinterest is no longer just an online vision board; it has become a shoppable platform with advertising conversion capabilities.

One of the major driving forces behind Pinterest’s transformation is the introduction of AI. The company has built a multimodal model that learns from both images and text to better understand what users are searching for. This serves as the driving force for personalized recommendations, and additionally, the “visual search” feature allows users to easily find and shop for products displayed in pinned images. On the other hand, on the backend, the “Performance+” platform provides advertisers with tools to implement more effective campaigns.

The results speak for themselves. In the previous quarter, Pinterest’s revenue surged by 16%. The average revenue per user (ARPU) has increased across all regions, and especially outside the US, Pinterest is advancing user monetization in emerging markets through its partnership with Alphabet [GOOGL].

Pinterest’s stock price remains at an attractive level, and the company has just begun working on monetizing its user base. With AI-powered tools and a more shopping-friendly platform, Pinterest has significant potential to become a solid long-term investment.

3. Dutch Bros Inc.

Dutch Bros Inc. [BROS] is becoming one of the most compelling growth stories in the restaurant industry. With over 1,000 locations across 18 states in the U.S., the company aims to double its store count to 2,029 by 2029, with the potential to eventually operate 7,000 coffee shops nationwide.

Drive-thru specialized small stores have the advantages of low construction costs, attractive unit economics, and a short payback period.

What is even more attractive is that Dutch Bros is about to start implementing important mechanisms for growth. For example, mobile ordering is still in its early stages but is steadily expanding, accounting for 11% of transactions in the previous quarter. Mobile ordering is integrated with the loyalty program, allowing for personalized marketing and promotions.

The company is also focusing on food, such as testing new products to boost breakfast sales at some locations. While food accounts for nearly 20% of Starbucks’ revenue, it represents less than 2% for Dutch Bros, indicating room for growth. With further menu expansion and new store openings on the horizon, Dutch Bros has the potential to become a long-term successful company.

4. Philip Morris International

Philip Morris International [PM] is a growth stock in the defensive industry. While many tobacco companies struggle with declining tobacco sales in the U.S., Philip Morris does not need to worry about that since it does not sell tobacco domestically. Instead, its portfolio of smokeless tobacco products, represented by “Zyn” and “Iqos,” which have higher economic efficiency per unit than traditional cigarettes, is driving growth.

The rapidly growing nicotine pouch brand Zyn is the company’s biggest growth driver, as evidenced by a 53% surge in shipments in the U.S. during the first quarter.

On the other hand, the company’s premium heated tobacco product, IQOS, continues to gain popularity in Europe and Japan, and has early success in new markets such as Mexico City, Jakarta, and Seoul. Furthermore, by buying back the rights from Altria Group [MO] in the United States, the U.S. holds potential as the next major growth driver. At the same time, the company’s traditional tobacco business maintains strong performance overseas, supported by robust pricing power and stable demand.

With strong pricing power, local production that mitigates the impact of tariffs, and the expanding demand for Zyn and IQOS, Philip Morris is well-positioned to achieve robust growth in the future.

5. Eli Lilly and Company

Eli Lilly and Company [LLY] has established itself as a leader in the rapidly growing GLP-1 drug market, with a surge in demand continuing to drive robust revenue growth. In the previous quarter, the company’s two main GLP-1 drugs, “Mounjaro” and “Zepbound,” reached sales of $6.1 billion combined, significantly increasing compared to the same period last year. Zepbound has been officially approved by the Food and Drug Administration (FDA) for weight loss in obese adults or overweight adults with at least one weight-related condition, while Mounjaro is approved for adults with type 2 diabetes. However, in reality, the growth of these drugs is being driven by off-label prescriptions for weight loss.

But the drug that could be the biggest game-changer for Eli Lilly is still in development. The company’s first oral GLP-1 drug candidate, Orforglipron, showed significant weight loss in patients taking the drug in a recent Phase 3 trial. Because it is an oral drug, it is much more convenient than the injectable GLP-1 drug, making it a particularly attractive option for patients who are reluctant to receive injections.

Furthermore, orforglipron does not require refrigeration or injection pens compared to injectable formulations, making manufacturing and distribution easier. As a result, Eli Lilly is expected to avoid supply constraints seen with its injectable GLP-1 portfolio. Orforglipron has the potential to become the most powerful oral GLP-1 weight loss medication on the market, positioning the company favorably for future sustained growth.

Disclaimer and Disclosure The article is intended for general informational purposes only and does not constitute investment advice to investors. The original author Geoffrey Seiler holds shares in Philip Morris International and Pinterest. The Motley Fool U.S. headquarters holds and recommends shares in Pinterest and Taiwan Semiconductor Manufacturing Company (TSMC). The Motley Fool U.S. headquarters recommends Dutch Bros and Philip Morris International. The Motley Fool U.S. headquarters has a disclosure policy.